tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Bayer says Gadoquatrane met primary, secondary endpoints in trial
PremiumThe FlyBayer says Gadoquatrane met primary, secondary endpoints in trial
21d ago
Bayer upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Bayer upgraded to Overweight from Equal Weight at Morgan Stanley
21d ago
Bayer welcomes Solicitor General support for U.S. Supreme Court review
Premium
The Fly
Bayer welcomes Solicitor General support for U.S. Supreme Court review
22d ago
Video: Biogen up after Novo weight-loss drug fails to slow Alzheimer’s progress
PremiumThe FlyVideo: Biogen up after Novo weight-loss drug fails to slow Alzheimer’s progress
30d ago
Bayer’s Asundexian met primary efficacy, safety endpoints in Phase III study
Premium
The Fly
Bayer’s Asundexian met primary efficacy, safety endpoints in Phase III study
1M ago
Bayer announces FDA approval of Hyrnuo for non-small cell lung cancer
Premium
The Fly
Bayer announces FDA approval of Hyrnuo for non-small cell lung cancer
1M ago
Bayer CFO says ‘general market growth trends intact’ for Consumer Health
PremiumThe FlyBayer CFO says ‘general market growth trends intact’ for Consumer Health
1M ago
Bayer reports Q3 core EPS EUR 0.57 vs. EUR 0.24 last year
Premium
The Fly
Bayer reports Q3 core EPS EUR 0.57 vs. EUR 0.24 last year
1M ago
Bayer expects to ‘significantly contain’ litigation risk by end of 2026
Premium
The Fly
Bayer expects to ‘significantly contain’ litigation risk by end of 2026
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100